Clinical Trial Update: Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020) [Phase 3]

View source ↗

Summary

Phase 3 trial updating lot-to-lot consistency of V114 in healthy adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections
• Pneumonia Pneumococcal

Drugs mentioned

• V114 (15-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Infections, Pneumonia, Pneumococcal | Phase 3 | Status: COMPLETED | Results posted: 2021-04-12